Department of Pharmacy, The Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou, Zhejiang, China.
Stomatology Hospital, School of Stomatology, Zhejiang University School of Medicine, Clinical Research Center for Oral Disease of Zhejiang Province, Key Laboratory of Oral Biomedical Research of Zhejiang Province, Cancer Center of Zhejiang University, Hangzhou, Zhejiang, China.
Antimicrob Agents Chemother. 2021 Aug 17;65(9):e0085421. doi: 10.1128/AAC.00854-21.
Tetracycline may cause tooth discoloration when used in young children during tooth development. Whether tigecycline, a tetracycline derivative, has either a similar adverse event or not remains unclear. We assessed the discoloration of the permanent teeth of patients <8 years old after tigecycline exposure. These patients were identified through a retrospective chart review in a Chinese children's hospital. Those who had at least one erupted permanent tooth after tigecycline exposure were interviewed, examined, and photographed by an experienced pediatric dentist and independently assessed by another senior dentist to detect tetracycline-like tooth discoloration. We identified 101 patients who were exposed to tigecycline, 12 of whom were included. The mean daily dose of tigecycline was 2.3 mg/kg of body weight (standard deviation, 0.6), and the median duration was 12.5 days (interquartile range [IQR], 8.0 to 19.3). The median age of exposure was 5.2 years (IQR, 4.5 to 7.4), and the median age of dental examination was 9.1 years (IQR, 9.0 to 10.3). Two patients (16.7%) developed yellow discoloration: a girl having yellow discoloration with white-to-yellow opacities in the upper lateral incisors and lower incisors and a boy with a suspicious buccal yellow discoloration and enamel dysplasia in the second molars. The incidence and extent of tigecycline-associated dental adverse events remain unclear due to the small sample size and inadequate follow-up period.
替加环素可能会在儿童牙齿发育期间导致幼儿的牙齿变色。作为四环素衍生物的替加环素是否具有类似的不良事件尚不清楚。我们评估了接受替加环素暴露后 <8 岁患者的恒牙变色情况。通过中国儿童医院的回顾性图表审查确定了这些患者。对至少有一颗恒牙萌出的患者进行了访谈、检查和拍摄,并由一位经验丰富的儿科牙医进行独立评估,以检测是否存在类似四环素的牙齿变色。我们确定了 101 名接受替加环素暴露的患者,其中 12 名被纳入研究。替加环素的平均日剂量为 2.3mg/kg 体重(标准差为 0.6),中位持续时间为 12.5 天(四分位距 [IQR],8.0 至 19.3)。暴露的中位年龄为 5.2 岁(IQR,4.5 至 7.4),牙科检查的中位年龄为 9.1 岁(IQR,9.0 至 10.3)。两名患者(16.7%)出现了黄色变色:一名女孩的上颌侧切牙和下颌切牙出现黄色变色伴白-黄不透明,另一名男孩的第二磨牙出现可疑颊侧黄色变色和釉质发育不良。由于样本量小且随访时间不足,替加环素相关不良牙齿事件的发生率和严重程度尚不清楚。